EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macrophage Cluster of Differentiation 163 promotes post‐infarction cardiac repair and preserves left ventricular function via osteopontin

Jingyu Chen, Linjian Chen, Wei Huang, Gang Wang, Lin Wang, Wanchun Mei, Wei Ni iD, Yang Liu, Licheng Ding, Xiaofeng Ge, Zhaokai Li, Jing Yu und 7 weitere

Clinical and Translational Medicine · 2026-04 · 16 (4)

DOI: 10.1002/ctm2.70662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 23.04.2026. Verfasst von Jingyu Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen Cardiovascular Hospital, School of Medicine, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Osteopontin, Myocardial Infarction, Antigens, Differentiation, Myelomonocytic, Antigens, CD. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Natural Science Foundation, Xiamen Medical and Health Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiac macrophages (cMacs) have been implicated in myocardial repair following myocardial infarction (MI), yet their therapeutic potential in ischaemic cardiomyopathy (ICM) remains limited by an incomplete understanding of their molecular regulation. Cluster of Differentiation 163 (CD163) is highly expressed in these macrophages, yet its functional role in regulating post‐MI cardiac repair remains unknown.

Methods

A cross‐sectional clinical study was conducted to assess the association between circulating soluble CD163 concentration and heart failure due to ICM. To investigate the functional contribution of CD163 in ICM, wild‐type (WT) and Cd163 − / − mice were subjected to permanent ligation of the left anterior descending coronary artery. Single‐cell RNA sequencing was employed to analyse transcriptional changes in cardiac immune cells. Recombinant osteopontin (OPN) and CD163 were administered to assess their therapeutic effect in Cd163 − / − mice.

Results

Circulating soluble CD163 levels were markedly elevated in patients with ICM‐induced heart failure compared with individuals without heart failure (median difference 34.5 ng/mL, IQR 13.6–54.6 ng/mL, p = .002) and showed a positive correlation with the extent of systolic dysfunction and left ventricular (LV) dilation. Cd163 − / − mice displayed aggravated LV systolic dysfunction, reduced ejection fraction and fractional shortening, impaired myocardial strain and reduced relative wall thickness post‐MI. Recombinant CD163 protein could reverse systolic dysfunction and LV dilation in Cd163 − / − mice after MI. CD163 was predominantly expressed in CCR2 − resident cMacs, and CD163 deficiency altered transcriptional programmes of macrophages without affecting their polarization status, with enrichment in cytokine signalling and extracellular matrix‐related pathways. Spp1 (OPN) expression was significantly downregulated in Cd163 − / − hearts under both sham and MI conditions. Administration of recombinant OPN improved systolic function, reduced ventricular dilation, decreased fibrotic scar size and restored the elastin‐to‐collagen ratio in Cd163 − / − mice.

Conclusions

In cMacs, CD163 contributes to post‐MI repair by upregulating OPN expression, which in turn helps maintain systolic function. Key points Soluble CD163 is elevated in ICM and correlates with LV dysfunction. Cd163 − / − mice show worsened post‐MI systolic dysfunction and dilation. Recombinant CD163 reverses dysfunction in Cd163 − / − mice. OPN restores function and improves LV structure in Cd163 − / − mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteopontinMyocardial InfarctionAntigens, Differentiation, MyelomonocyticAntigens, CDReceptors, Cell SurfaceMacrophagesVentricular Function, LeftAnimalsCD163 AntigenMiceMaleHumansFemaleCross-Sectional StudiesMiddle Aged

Stichwörter der Autor:innen

CD163heart failuremyocardial infarctionosteopontinventricular dilation

Substanzen

OsteopontinCD163 AntigenAntigens, Differentiation, MyelomonocyticAntigens, CDReceptors, Cell Surface

Autor:innen und Institutionen

  • Xiamen Cardiovascular Hospital, School of Medicine, Xiamen University, Xiamen, China.
  • Department of Cardiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
  • Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

ORCID-Profile: Wei Ni, Binbin Liu

Förderung

  • National Natural Science Foundation of China
  • Fujian Natural Science Foundation
  • Xiamen Medical and Health Project
  • National Key Research and Development Program of China

Zitieren

APA

Chen, J., Chen, L., Huang, W., Wang, G., Wang, L., Mei, W., Ni, W., Liu, Y., Ding, L., Ge, X., Li, Z., Yu, J., Huang, S., Lin, J., Chen, Y., Cai, B., Zhang, P., Dai, C., & Liu, B. (2026). Macrophage Cluster of Differentiation 163 promotes post‐infarction cardiac repair and preserves left ventricular function via osteopontin. Clinical and Translational Medicine, 16(4). https://doi.org/10.1002/ctm2.70662

Vancouver

Chen J, Chen L, Huang W, Wang G, Wang L, Mei W, et al. Macrophage Cluster of Differentiation 163 promotes post‐infarction cardiac repair and preserves left ventricular function via osteopontin. Clinical and Translational Medicine. 2026;16(4). doi:10.1002/ctm2.70662

BibTeX
@article{Chen2026,
  author = {Chen, Jingyu and Chen, Linjian and Huang, Wei and Wang, Gang and Wang, Lin and Mei, Wanchun and Ni, Wei and Liu, Yang and Ding, Licheng and Ge, Xiaofeng and Li, Zhaokai and Yu, Jing and Huang, Shufen and Lin, Jiayi and Chen, Yifan and Cai, Binni and Zhang, Peng and Dai, Cuilian and Liu, Binbin},
  title = {Macrophage Cluster of Differentiation 163 promotes post‐infarction cardiac repair and preserves left ventricular function via osteopontin},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.1002/ctm2.70662}
}
Kostenlos starten →